Inventor
GRAEBER MICHAEL
US31 patents
⚠️ This page may combine multiple inventors who share the name “GRAEBER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALDERMA RES & DEV
12 patentsUS7642288B2Jan 5, 2010
Topical application of adapalene for the long-term treatment of acne vulgaris
GALDERMA RES & DEV23 citations92
US7579377B2Aug 25, 2009
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV17 citations92
US9622994B2Apr 18, 2017
Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GALDERMA RES & DEV4 citations83
US9387187B2Jul 12, 2016
Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations83
US9381179B2Jul 5, 2016
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations83
US7868044B2Jan 11, 2011
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GALDERMA RES & DEV2 citations73
US7838558B2Nov 23, 2010
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV2 citations73
US7834060B2Nov 16, 2010
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations73
US7737181B2Jun 15, 2010
Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations73
US9901556B2Feb 27, 2018
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV0 citations51
US9872842B2Jan 23, 2018
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV0 citations51
USD758048SJun 7, 2016
Garment
GALDERMA RES & DEV0 citations36
GRAEBER MICHAEL
9 patentsUS8703820B2Apr 22, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL7 citations92
US8410102B2Apr 2, 2013
Methods and compositions for treating or preventing erythema
GRAEBER MICHAEL15 citations90
US8513247B2Aug 20, 2013
Methods and compositions for safe and effective treatment of erythema
GRAEBER MICHAEL15 citations89
US8513249B2Aug 20, 2013
Methods and compositions for safe and effective treatment of erythema
GRAEBER MICHAEL13 citations89
US8729127B2May 20, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL6 citations83
US8809305B2Aug 19, 2014
Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
GRAEBER MICHAEL4 citations67
US8921423B2Dec 30, 2014
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GRAEBER MICHAEL1 citations62
US8653140B2Feb 18, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL1 citations62
US8916562B2Dec 23, 2014
Methods and compositions for safe and effective treatment of telangiectasia
GRAEBER MICHAEL3 citations61
GALDERMA SA
4 patentsUS9233118B2Jan 12, 2016
Treatment of papulopustular rosacea with ivermectin
GALDERMA SA12 citations90
US9233117B2Jan 12, 2016
Treatment of inflammatory lesions of rosacea with ivermectin
GALDERMA SA12 citations88
US10206939B2Feb 19, 2019
Treatment of papulopustular rosacea with ivermectin
GALDERMA SA0 citations49
US9782425B2Oct 10, 2017
Treatment of papulopustular rosacea with ivermectin
GALDERMA SA1 citations49